You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4151 to 4175 of about 5880
Next 25
11/22/2006
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts
The course of neurocognitive functioning in high-grade glioma patients
Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol)
The pathophysiologic mechanism of cerebellar mutism.
11/21/2006
University Evaluates New Device To Treat Brain Tumors
11/20/2006
Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
NEOPHARM AnNOUNCES Presentation of FINAL SAFETY DATA FROM PHASE 1 TRIAL OF CINTREDEKIN BESUDOTOX for Newly Diagnosed Malignant Glioma
11/19/2006
Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual Meeting of the Society For Neuro-Oncology
11/18/2006
Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer
NCI Best Case Series for CAM: Outcomes in Treatment of Brain Tumors
Vaccine for brain tumors shows promising results
11/10/2006
Reata Announces Presentation of Interim Results for Phase 1 Study of RTA 744 in Treatment of Advanced Brain Tumors
Anti-cancer virus kills brain cancer cells
Jefferson Oncologists Show Less Radiation Just as Effective in Fighting Brain Tumor, Saving Hearing
A lesson in Living
Northwest Biotherapeutics Discusses Results From Clinical Trials In Brain Cancer At Two Conferences
Newly identified biomarker detects and regulates spread of brain tumors
Neurospheres Enriched in Cancer Stem-Like Cells Are Highly Effective in Eliciting a Dendritic Cell-Mediated Immune Response against Malignant Gliomas.
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial.
Commercial flight and patients with intracranial mass lesions: a caveat. Report of two cases.
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
AACR Science Policy Alert
10/31/2006
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.